13F Data
13F filer · CIK 1425738

Redmile Group, LLC

LARKSPUR, CA · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$1.5B
$-20.6M vs prior
Positions
39
New / sold out
4 / 0
Added / reduced
5 / 23
Turnover
6.7%
buys $100.2M · sells $445.6M
Top-10 weight
73.5%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedAGOMAB THERAPEUTICS NV+2,577,676+1649.7%+$33.5M
NewCLIMB BIO INC+1,226,330–+$16.0M
NewAURA BIOSCIENCES INC+1,666,667–+$11.8M
AddedSHATTUCK LABS INC+1,352,309+24.4%+$9.4M
NewODYSSEY THERAPEUTICS INC+425,000–+$8.0M
AddedCELLDEX THERAPEUTICS INC NEW+172,413+65.9%+$6.4M
NewINSMED INC+51,234–+$5.5M
AddedBIOMARIN PHARMACEUTICAL INC+91,310+52.5%+$5.2M
AddedIDEAYA BIOSCIENCES INC+119,085+22.9%+$4.4M

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedSCHOLAR ROCK HLDG CORP-4,755,529-52.5%$-261.6M
ReducedNURIX THERAPEUTICS INC-3,659,021-47.3%$-88.8M
ReducedABSCI CORPORATION-1,513,641-18.3%$-17.5M
ReducedKRYSTAL BIOTECH INC-41,500-6.2%$-15.4M
ReducedANNEXON INC-2,679,891-18.4%$-15.3M
ReducedIMMUNOME INC-647,295-11.6%$-13.7M
ReducedCOGENT BIOSCIENCES INC-184,715-26.8%$-7.1M
ReducedSTOKE THERAPEUTICS INC-218,200-5.2%$-7.1M
ReducedADC THERAPEUTICS SA-3,943,792-25.5%$-4.2M
ReducedBEAM THERAPEUTICS INC-73,400-5.9%$-2.5M
13 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $567.5MQ3 2013: $664.0MQ4 2013: $810.4MQ1 2014: $837.6MQ2 2014: $824.5MQ3 2014: $865.8MQ4 2014: $918.4MQ1 2015: $1.1BQ2 2015: $1.2BQ3 2015: $1.3BQ4 2015: $1.3BQ1 2016: $977.1MQ2 2016: $1.0BQ3 2016: $1.3BQ4 2016: $1.2BQ1 2017: $1.5BQ2 2017: $1.6BQ3 2017: $2.0BQ4 2017: $2.3BQ1 2018: $2.6BQ2 2018: $2.9BQ3 2018: $3.3BQ4 2018: $2.5BQ1 2019: $3.4BQ2 2019: $3.5BQ3 2019: $3.0BQ4 2019: $4.2BQ1 2020: $3.6BQ2 2020: $5.4BQ3 2020: $5.4BQ4 2020: $8.3BQ1 2021: $7.1BQ2 2021: $6.8BQ3 2021: $5.7BQ4 2021: $4.4BQ1 2022: $3.2BQ2 2022: $2.6BQ3 2022: $2.6BQ4 2022: $2.4BQ1 2023: $2.3BQ2 2023: $2.6BQ3 2023: $2.1BQ4 2023: $2.8BQ1 2024: $2.7BQ2 2024: $1.7BQ3 2024: $1.7BQ4 2024: $1.4BQ1 2025: $1.1BQ2 2025: $939.6MQ3 2025: $1.0BQ4 2025: $1.4BQ1 2026: $1.5BQ2 2026: $1.5B
Q2 2013Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1SCHOLAR ROCK HLDG CORPCOM4,311,092$237.1M15.92%
2KRYSTAL BIOTECH INCCOM632,005$234.9M15.77%
3STOKE THERAPEUTICS INCCOM3,945,920$129.1M8.67%
4IMMUNOME INCCOM4,911,590$104.1M6.99%
5NURIX THERAPEUTICS INCCOM4,073,787$98.8M6.64%
6ABSCI CORPORATIONCOM6,739,675$78.1M5.24%
7ANNEXON INCCOM11,869,877$67.8M4.55%
8REGENXBIO INCCOM4,368,804$52.3M3.51%
9SHATTUCK LABS INCCOM6,892,033$47.8M3.21%
10NEUROGENE INCCOM1,412,199$44.4M2.98%
29 more rows. Subscribe for $29/month to see every row, download the data and use the API.